Cancel culture for cancer research: Proposed rule politicizes federal grantmaking
The proposed federal regulation would shift the process of awarding federal grants from a merit-based, apolitical, expert-driven system to a partisan political one, allowing political appointees in th
The proposed federal regulation would shift the process of awarding federal grants from a merit-based, apolitical, expert-driven system to a partisan
Read Full Story at The Hill →Why This Matters
The proposed rule represents a fundamental erosion of the scientific and medical research ecosystem in the United States, where cancer research has long thrived under a system designed to prioritize peer-reviewed excellence over political whims. By introducing partisan oversight into grantmaking, it risks undermining decades of progress in oncology, immunology, and public health—fields where federal funding has been a cornerstone of global leadership.
Background Context
Since the National Institutes of Health (NIH) and National Cancer Institute (NCI) were established in the mid-20th century, their funding mechanisms have operated on a bipartisan consensus that scientific merit, not political affiliation, should guide research priorities. Past attempts to politicize grant decisions—such as the 2016 restrictions on fetal tissue research—were met with backlash from both the scientific community and Congress, underscoring the fragility of this norm.
What Happens Next
If enacted, the rule could trigger immediate legal challenges from academic institutions, research coalitions, and civil liberties groups, potentially tying up implementation in court for years. Meanwhile, early-career researchers and underrepresented groups in science may face heightened scrutiny, altering the demographic landscape of federally funded cancer research. Congress could also step in, either through legislation or budgetary restrictions, to rein in the policy’s most contentious elements.
Bigger Picture
This move aligns with a broader pattern of recent federal efforts to centralize control over independent scientific institutions, mirroring similar pressures in environmental, agricultural, and climate research. It also reflects a growing tension between evidence-based policymaking and the demands of ideological constituencies, a dynamic that could reshape the federal government’s role as a steward of public health research for decades to come.
